(2) what recent discussions he has had with pharmaceutical companies on generic substitution.
We are currently refining our proposals for the implementation of generic substitution. The start date for the consultation process has not yet been agreed but we still expect this to start later this autumn. We expect the consultation period will last 12 weeks and the exact timetable for implementation will therefore be influenced by the outcome of this consultation.
In order to inform proposals, departmental officials have been discussing the introduction of generic substitution with the Association of the British Pharmaceutical Industry, the Ethical Medicines Industry Group, the British Generic Manufacturers Association, the Pharmaceutical Services Negotiating Committee and the General Practitioners’ Committee of the British Medical Association.